Trial Profile
Arthralgia and changes in serum levels of IGF-I, its binding protein and estrogen in breast cancer patients on endocrine agents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2014
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary) ; Aromatase inhibitors
- Indications Early breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 15 Sep 2014 New trial record